(MedPage Today) — The FDA gathered public feedback Monday during a 4-hour hearing about potential therapeutic use of psychedelic drugs.
Most of the hearing’s 80 speakers offered strong support for psychedelic medicine, highlighting its efficacy…
Source link
Psychedelic Drug Trials, Patient Safety Take Spotlight at FDA Hearing
Show Comments (0)
Hide Comments (0)
0
0
votes
Article Rating
Subscribe
Login
0 Comments
Oldest
Newest
Most Voted
Inline Feedbacks
View all comments
